Associated Papers
Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity.
Kimura H et al.
Elife, 2025
40238651 (PubMed )
Supplement: elife-95347-supp10.xlsx › Appendix_1-table_10
Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity.
Kimura H et al.
Biorxiv : the Preprint Server for Biology, 2025
38234851 (PubMed )
Supplement: media-2.pdf
Detection of somatic copy number deletion of the CDKN2A gene by quantitative multiplex PCR for clinical practice.
Tian Y et al.
Frontiers in Oncology, 2022
36531022 (PubMed )
Supplement: DataSheet_1.zip › Data_file-3_CDKN2A-TCGA-cancer_Conan_tableviewFri_Mar__5_07_32_41_2021__1_.xlsx › Conan_tableviewFri_Mar__5_07_32
CDKN2A-Inactivated Pancreatic Ductal Adenocarcinoma Exhibits Therapeutic Sensitivity to Paclitaxel: A Bioinformatics Study.
Lin JC et al.
Journal of Clinical Medicine, 2020
33322698 (PubMed )
Supplement: jcm-09-04019-s001.zip › jcm-1006906supple › Table-S1-TCGA-data.xlsx › _e__SKCM
Select a paper to view details